Andreas Kortgen, Markus Paxian, Marco Werth, Peter Recknagel, Falk Rauchfu, Amelie Lupp, Claus G. Krenn, Dieter Müller, Ralf A. Claus, Konrad Reinhart, Utz Settmacher, Michael Bauer
2009 Shock  
Liver dysfunction affects a variety of metabolic pathways in the critically ill but mechanisms remain poorly understood. We prospectively assessed markers of hepatic injury and function in sepsis and ischemia/reperfusion injury in vivo and molecular mechanisms in human liver tissue ex vivo. Markers of hepatocellular injury, synthesis, and excretion, including plasma disappearance rate of indocyanine green, were measured in 48 patients with severe sepsis. Incidence of liver dysfunction was 42%
more » ... sfunction was 42% as assessed by hyper-bilirubinemia but 74% by impaired dye excretion. Conventional markers for liver injury failed to predict outcome, while dye excretion <8%/min predicted death with high sensitivity and specificity. Potential mechanisms were assessed via 1) gene expression analysis of transporter proteins for bilirubin and indocyanine green in cultured human liver tissue, and 2) monitoring uptake and excretion of the dye after ischemia/reperfusion injury in 12 patients receiving a biliary T-tube during liver transplant. Ex vivo gene expression of transporters was differentially affected for bilirubin and indocyanine green with up-regulation of basolateral and down-regulation of canalicular indocyanine green transporters. Consistently, patients with unfavorable course after liver transplantation displayed almost complete cessation of biliary dye excretion while uptake into the hepatocyte was reduced by only 40%. In conclusion, standard liver tests lack the required sensitivity to assess hepatic injury and function in the critically ill. Dye excretion better reflects excretory and/or microvascular dysfunction but still underestimates impaired canalicular transport. The observed differential susceptibility of the polar surfaces of human hepatocytes has potential implications for monitoring liver function and drug-induced liver injury.
doi:10.1097/shk.0b013e31819d8204 pmid:19197231 fatcat:ow3asxuf3netpgvkoo4cjpjela